Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1983
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 1
1985 1
1986 3
1987 4
1988 2
1989 4
1990 2
1991 1
1992 6
1993 6
1994 13
1995 14
1996 10
1997 17
1998 26
1999 22
2000 36
2001 36
2002 33
2003 63
2004 84
2005 102
2006 144
2007 130
2008 153
2009 171
2010 185
2011 248
2012 262
2013 333
2014 396
2015 487
2016 474
2017 510
2018 612
2019 717
2020 754
2021 935
2022 1075
2023 988
2024 1102
2025 60

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

9,085 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Guo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z. Guo Y, et al. Among authors: wei q. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19. J Med Chem. 2019. PMID: 31381333
BRD4: an effective target for organ fibrosis.
Wei Q, Gan C, Sun M, Xie Y, Liu H, Xue T, Deng C, Mo C, Ye T. Wei Q, et al. Biomark Res. 2024 Aug 30;12(1):92. doi: 10.1186/s40364-024-00641-6. Biomark Res. 2024. PMID: 39215370 Free PMC article. Review.
9,085 results